In vitro effect of 5-fluorouracil and paclitaxel on Echinococcus granulosus larvae and cells

ContentslistsavailableatScienceDirect

Acta Tropica

j ou rn a l h o m epa g e :w w w . e l s e v i e r . c o m / l o c a t e / a c t a t r o p i c a

In vitro effect of 5-fluorouracil and paclitaxel on Echinococcus granulosus larvae and cells

P.E. Pensel

, C. Albani

, G. Ullio Gamboa

, J.P. Benoit

, M.C. Elissondo

aLaboratoriodeZoonosisParasitarias,Fac.CienciasExactasyNaturales,UniversidadNacionaldeMardelPlata,CONICET,MardelPlata,Argentina

bLaboratoriodeFarmacotecnia,Fac.CienciasQuímicas,UniversidadNacionaldeCórdoba,UNITEFA,Córdoba,Argentina

cConsejoNacionaldeInvestigacionesCientíficasyTécnicas(CONICET),BuenosAires,Argentina

dINSERMU1066,MINT—MicroetNanomédecinesBiomimétiques,IBS-CHUAngers,49933AngersCedex9,France

a r t i c l e i n f o

Articlehistory:

Received26March2014

Receivedinrevisedform27June2014 Accepted23July2014

Availableonline1August2014

Keywords:

Cystechinococcosis Echinococcusgranulosus Hydatidcysts 5-Fluorouracilo Paclitaxel

a b s t r a c t

HumancysticechinococcosisisazoonosiscausedbythemetacestodestageofthetapewormEchinococcus granulosus.Althoughbenzimidazolecompoundssuchasalbendazoleandmebendazolehavebeenthe cornerstoneofchemotherapyforthedisease,thereisoftennocompleterecoveryaftertreatment.Hence, insearchingfornoveltreatmentoptions,weexaminedtheinvitroefficaciesof5-fluorouracil(5-FU)and paclitaxel(PTX)againstE.granulosusgerminalcells,protoscolecesandcysts.5-FUorPTXinhibitedthe growthofE.granulosuscellsinatimedependentmanner.Althoughbothtreatmentshadaprotoscolicidal effect,5-FUhadaconsiderablystrongereffectthanPTX.5-FUproducedadose-andtime-dependent effect,provokingthecompletelossofviabilityafter24daysofincubation.Moreover,cystsdidnotdevelop followingtheinoculationoftreatedprotoscolecesintomice.ThelossofviabilitywasslowerinPTXtreated protoscoleces,reachingtoapproximately60%after30days.Theresultsoftheinvitrotreatmentwith5- FUandPTXweresimilarinsecondarymurinecysts.TheemploymentofSEMandTEMallowedusto examine,atanultrastructurallevel,theeffectsinducedby5-FUandPTXonE.granulosusgerminalcells, protoscolecesandmurinecysts.Inconclusion,thedataobtainedclearlydemonstratedthat5-FUandPTX atclinicallyachievableconcentrationsinhibitthesurvivaloflarvalcells,protoscolecesandmetacestodes.

Invivostudiestotesttheantiparasiticactivitiesof5-FUandPTXarecurrentlybeingundertakenonthe murinemodelofcysticechinococcosis.

©2014ElsevierB.V.Allrightsreserved.

1. Introduction

Cystic echinococcosis (CE)caused by the larval stageof the tapewormEchinococcusgranulosusisachronic,complex,andstill neglectedparasiticinfectiondisease(Brunettietal.,2011).Human orungulateintermediatehosts(sheep,goats,pigs,cattle,horses orcamels)becomeinfectedafteringestionofeggspassedintothe environmentwithfaecesfromdefinitivehosts(dogsandwolves).

Theoutcomeofinfectionisthedevelopmentoffluid-filledcysts mainlyintheliverandthelungs,althoughotherorganscanalsobe affected(Budkeetal.,2013).

The WHO-IWGE classification providesthe basis for choos- ing basically four treatment and management options for CE: surgery, percutaneous sterilization, chemotherapy with

∗Correspondingauthorat:LaboratoriodeZoonosisParasitarias,FacultaddeCien- ciasExactasyNaturales,UniversidadNacionaldeMardelPlata(UNMdP),Funes 3250,7600MardelPlata,Argentina.Tel.:+542234752426;fax:+542234753150.

E-mailaddresses:[email protected],[email protected](M.C.Elissondo).

benzimidazolesandobservation(watchandwait)forinactive,clin- icallysilentcysts(Brunettietal.,2011).Eachofthesetherapeutic toolshaslimitationsdependingontheindividualcase.Theevi- dencesupportinganyofthesemodalitiesfromcarefullydesigned clinicalstudiesisinsufficientandthechoiceoftreatmentoptions remainscontroversial(Stojkovicetal.,2009).

Medical treatmentis indicatedwhen surgicalremoval isnot appropriateforpatientswithmultiplecystsintwoormoreorgans, forpreventionof secondaryechinococcosisaftersurgery andin somecasesforpresurgicaltreatment(Pawlowskietal.,2001).The benzimidazole(BZ)compounds–albendazole(ABZ)andmeben- dazole(MBZ)–havebeenthecornerstoneofchemotherapyforCE (McManusetal.,2012).

Severalfactorsaffecttheresponsetomedicaltreatment,suchas sizeandageofthecysts,thicknessofhostderivedconnectivetis- sue,calcification,cystcomplicationwithmultiplecompartments ordaughtercysts,abilityofthedrugtopenetratethecystwalland persistenceofadequatelevelof drugoritsactivemetaboliteat thesiteofparasitelocation(Ceballosetal.,2008;Hemphilland Müller,2009).ApproximatelyathirdofpatientstreatedwithBZ http://dx.doi.org/10.1016/j.actatropica.2014.07.013

0001-706X/©2014ElsevierB.V.Allrightsreserved.

drugshavebeencured,30–50%developsomeevidenceofathera- peuticresponsewhilebetween20and40%ofcasesdonotrespond favorably(MoroandSchantz,2009).Moreover,BZsometimesacts exclusivelyasaparasitostaticagent,andrelapsesafterchemother- apyhavebeenreported(Stamatakosetal.,2009).

Praziquantel(PZQ),aheterocyclicpyrazinoisoquinolinederiva- tive,hasbeenproposedtobeusedalongsideBZinCE-patients.

Nevertheless,furtherstudiesarerequiredtodeterminewhether there are significantbenefitsfrom a combination therapy with ABZandPZQovermonotherapywithABZ(Bygott andChiodini, 2009).Withregardtothesedifficulties,thedevelopmentofanew therapeuticdrugforhumantreatmentofcysticechinococcosisis necessary.

There are a number of similarities between cancer cells and some parasites (Klinkert and Heussler, 2006). Particu- larly,Echinococcusmetacestodesexhibittumor-likeproperties,as reflectedbytheirseeminglyunlimited growthand proliferation potential,andtheirabilitiestomodulatetheimmuneresponseand toformmetastases(Hemphilletal.,2007).Consequently,several drugsinhibitingproliferationofcancercellshavebeenassayedon Echinococcusmetacestodesandprotoscoleces(HemerandBrehm, 2012;Hübneretal.,2010;Küsteretal.,2012;Lianceetal.,1993;

Naguleswaranetal.,2006;Spicheretal.,2008a,b).Doxorubicin, adrugcommonlyusedinthetreatmentofawiderangeofcan- cers,showedinvivoparasiticidalpropertiesagainstE.multilocularis afterbindingtopolyisohexylcyanoacrylatenanoparticles(Liance etal.,1993).Theinvitroandinvivoeffectsof2-methoxyestradiol, artemisininandartemisininderivativesagainstE.granulosusandE.

multilocularislarvalstageswereevaluated(Spicheretal.,2008a,b).

Furthermore,theisoflavonegenisteinandthegenisteinderivative Rm6423exhibited profoundinvitro activitiesagainstthemen- tionedparasites(Naguleswaranetal.,2006).

Fluoropyrimidineweredevelopedinthe1950sfollowingthe observationthatrathepatomasusedexogenousuracilmorerapidly than normal tissues, indicating that uracil metabolism was a potentialtargetforantimetabolitechemotherapy(Rutmanetal., 1954).Heidelbergerandcolleaguessynthesized5-fluorouracil(5- FU), which differs from uracil by virtue of a flourine atom in placeofhydrogenatthecarbon-5positionofthepyrimidinering (Heidelbergeretal.,1957).Thisdrugiswidelyusedinthetreat- mentofarangeofcancersincludingbreastcancerandcancersof theaerodigestivetract,buthashadthegreatestimpactincolorectal tumors(Longleyetal.,2003).5-FUhasinvitroandinvivoantiprolif- erativeeffectonendometrioticcells(Ngôetal.,2010).Furthermore, anti-malarialactivityof5-FUagainstPlasmodiumfalciparumhas beendemonstrated(Rathodetal.,1989).

Anotheranticanceragentisaditerpeneplantproductderived fromthewesternyew Taxus brevifolia,namelypaclitaxel(PTX) (Wanietal.,1971).PTXhasantineoplasticpropertiesandisused totreatcertainhumanmalignancies(RowinskyandDonerhower, 1995;Huizingetal.,1995).InvitrostudieshaveshownthatPTX inhibitsthegrowthoftheapicomplexanparasitesP.falciparumand Toxoplasmagondii(Pouvelleetal.,1994;Estesetal.,1998).

Theaimofthepresentworkwastodeterminetheinvitroeffect of5-FUandPTXagainstE.granulosusgerminalcells,protoscoleces andcyst.

2. Materialsandmethods

2.1. Drugtreatments

Paclitaxel(Indena,Milan,Italy)and5-FU(RocheLaboratories, Neuilly-sur-Seine, France) were dissolvedin dimethyl sulphox- ide(DMSO) atadrugconcentrationof10mg/ml.5-FUand PTX were added to the medium 199 (Gibco BRL) resulting in final

concentrationsof10,5and1␮g/ml(5-FU:75,37.5,7.5␮M;PTX:12, 6,1.2␮M).Thefinalvolumeofdrugsolutionaddedtothemedium was0.1%.Controlculturecontained0.1%DMSO.

2.2. Parasitematerialandcellculture

Hydatidcystsfromliverandlungsofnaturallyinfectedcattle wereobtainedfromaslaughterhouselocatedinthesoutheastof theBuenosAiresprovince,Argentina.E.granulosuscellculturewas obtainedusingpreviouslyreportedmethods(Albanietal.,2010).

Inbrief,cellswereculturedat37^◦Cinmedium199supplemented with 10% FBS, 10% hydatid fluid, reducing agents (5×10⁻⁵M 2-mercaptoethanol and 100␮M l-cysteine), 2mM l-glutamine (Bio-Rad,USA),40␮g/mlglucose(Sigma,USA),1mMsodiumpyru- vate (Sigma, USA) and antibiotics (penicillin, streptomycin and gentamicin100␮g/ml).E.granulosuscells werecultivatedforat least4weeks.Theculturemediumwaschangedweeklyandcells weresubculturedonceaweekatasplitratio1:2(Albanietal., 2010).

2.3. Growthinhibitoryassayonisolatedcells

E.granulosuscellswereseededin24-wellmicroplates(5×10⁵ cells/wellin1mlmedium).Forthisexperimentcellculturesafter 24hofsubculturewereused.5-FUandPTXwereaddedinserial concentrations(10,5and1␮g/ml)andcultureswereincubatedfor 7days.Atdays0,2,5and7viabilitywasassessedbytrypanblue dye(Sigma,USA)exclusionusingahemocytometer.Cultureswere followedmicroscopicallytodeterminetheappearanceofmorpho- logicalalterations.Atdays2,5and7oftreatment,sampleswere takenforscanningelectronmicroscopy(SEM).

2.4. Protoscolecescollectionandinvitroincubationprocedures Protoscoleceswereremovedfromcystsunderasepticcondi- tionsandwashed severaltimeswithphosphate-bufferedsaline (PBS, pH 7.2). Viability was assessed as previously described (Elissondoetal.,2006).Viableandfree protoscoleces(2000per Leightonttube)wereculturedin10mlofmedium199,containing 60␮g/mlpenicillin,100␮g/mlstreptomycin, 50␮g/mlgentami- cinand4mg/mlglucose.Invitroincubationswereperformedat 37^◦C withoutchangesofmedium.5-FUandPTXwereaddedto themediumresultinginfinalconcentrationsof10,5and1␮g/ml.

Culturetubeswerefollowedmicroscopicallyeveryday.Samples ofprotoscoleces(approximately90–100protoscolecesin180␮lof incubationmedium)fromeachtreatmentandthecontrolswere takenevery5–6daysforviabilityassessment.Allexperimentswere performedintriplicateandwererepeatedthreetimes.Addition- ally,ultrastructuralstudieswithSEMandtransmissionelectron microscopy(TEM)wereperformed.

2.5. Ethicstatement

Animalproceduresandmanagementprotocolswerecarriedout in accordance withthe 2011revised formof The Guide for the CareandUseofLaboratoryAnimalspublishedbytheU.S.National Institute of Health. Unnecessary animal suffering was avoided throughoutthestudy.CF-1mice(bodyweight25±5g)wereused.

Theanimalswerehousedinatemperature-controlled(22±1^◦C), light-cycled(12-hlight/darkcycle)room.Foodand waterwere givenadlibitum.

2.6. Determinationofinfectivitytomice

Viableandfreeprotoscoleces(2000perLeightonttube)were culturedin10mlofmedium.5-FUwasaddedtothemediumat

Fig.1.SurvivalofE.granulosuslarvalcellsaftertreatmentwith5-FUandPTX.Eachpointrepresentsthemeanpercentageofvitalcellsfromthreedifferentexperiments (DMSO:dimethylsulphoxide).

afinalconcentrationof10␮g/ml.Protoscolecesincubatedincul- turemediumcontainingDMSOservedascontrols.At24dayspost incubation (p.i.),protoscoleces ofeither 5-FUorcontrol groups wererinsedinmedium199.Aftersedimentation,theywereresus- pendedinmedium199supplemented with60␮g/ml penicillin, 100␮g/mlstreptomycinand50␮g/mlgentamicinandtheconcen- trationwasadjustedto3000protoscoleces/ml.Eachexperiment wasperformedinquadruplicate.

EightCF-1micewereallocatedintotwogroups(n=4):Thecon- troland5-FUgroups wereinfected byintraperitoneal injection with0.5mlofprotoscolecessuspensionfrominvitroDMSOand5- FUtreatments,respectively.At7monthspostinfection,micewere necropsiedandexaminedforlarvalgrowth.

2.7. Mouseinfectionandcollectionofcysts

FemaleCF-1micewereinfectedbyintraperitonealinoculation with1500E.granulosusprotoscoleces/animal,suspendedin0.5ml of medium199(Gibco). At8 monthspost-infection,mice with experimentalsecondaryCEwereeuthanized,andnecropsywas carried out immediatelythereafter. Atnecropsy, theperitoneal cavitywasopenedandthehydatidcystswerecarefullyremoved (Elissondoetal.,2009).

2.8. Proceduresforinvitroincubationofcysts

Groupsof10cysts(2–5mm)wereplacedinLeightontubescon- taining10mlofmedium199with5-FUorPTXatthefollowingfinal concentrationsof10,5and1␮g/ml.Culturesweremaintainedat 37^◦Cwithoutchangesofmediumduringtheentiredrugincubation period(Elissondoetal.,2007).Culturetubeswerefollowedmacro- andmicroscopicallyeveryday.Samplesofcystsfromeachofthe dosinggroupsandthecontrolsweretakenandthenfixedforelec- tronmicroscopy.Thecriteriaforcystsvitalitywasassessedonthe basisofstructuralvesicleintegrityandtheultrastructuralobserva- tionofthegerminallayerasdescribedbyElissondoetal.(2007).All

experimentswereperformedintriplicateandwererepeatedthree times.

2.9. Electronmicroscopy

E.granulosuscellsampleswereprocessedfor SEM(scanning electronmicroscopy)usingtheprotocoldescribedinAlbanietal.

(2010).Samplesofprotoscolecesandcystsculturedinvitrowere processedforSEMandTEMasdescribedbyElissondoetal.(2006, 2007).

2.10. Statisticalanalysis

Log-ranktestwasusedtoassessthesurvivaldifferencesoflarval cells andprotoscolecesafterexposureto5-FUandPTX.Allsta- tisticalanalyseswereperformedusingtheBioEstat5.0software (Ayresetal.,2007).Pvalueslessthan0.05wereconsideredtobe statisticallysignificant.

3. Results

3.1. InvitroE.granulosuscellculture

Theeffectof5-FUandPTXonthegrowthofE.granulosuscells isshowninFig.1.Controltreatmentalwaysshowedanincreasein cellnumberreachinganaverageof1.5×10⁶totalcellsatday7.

Incontrast,5-FUandPTXinhibitedthegrowthofE.granulo- suscellsinatimedependentmanner.At5daysp.i.,thenumber oftreated-cellswas64%lowerthanthatobservedinuntreated- cells. Besides,5-FUand PTXat aconcentrationof 10␮g/mlnot onlyinhibitedthegrowthofcellsbutalsoprovokedaconsiderable reductioninthecellnumberafter7days.

StudiesbySEMrevealedthatstructuraldamagewasproduced indrug-treatedcells(Fig.2).At7daysp.i.,cellsincubatedwith 10␮g/mlof5-FUorPTXshowedmorphologicalalterationaslossof turgidity,cellularcontractionandpresenceofblebsonthesurface.

Fig.2. ScanningelectronmicroscopyofE.granulosusisolatedlarvalcellsincubatedinvitrowith5-FUandPTXduring7days.(a)Control(1400×);(b)detailofcontrolcells (10,000×);(c)cellstreatedwith10␮g/ml5-FU(10,000×);(d)cellstreatedwith10␮g/mlPTX(10,000×).

Fig.3.SurvivalofE.granulosusprotoscolecesafterexposureto5-FUandPTX.Eachpointrepresentsthemeanpercentageofvitalprotoscolecesfromthreedifferent experiments(DMSO:dimethylsulphoxide).

3.2. Invitroprotoscolecesincubation

ThesurvivalofE.granulosusprotoscolecesincubatedwithdif- ferentconcentrationsofof5-FUandPTXisshowninFig.3.Although bothtreatmentshadaprotoscolicidaleffect,5-FUhadaconsider- ablystrongereffectthandidPTX.

Control protoscoleces cultured in medium 199+DMSO remainedviable(94.7±0.2%)after30daysofincubation(Fig.3).No changesinstructureandultrastructurewereobservedthroughout theexperimentalperiod(Figs.4a,5a,5band6a).

Treatment with 5-FU produced dose- and time-dependent effects(Fig.3).Themaximumprotoscolicidaleffectwasfoundwith 10␮g/mlof5-FU.Viabilitywasreducedto28.3±8.4%after18days ofincubationandreached0%after24days.Lossofprotoscolecex viabilityin5␮g/mltreatedculturesbecameclearerafter18days, wherethepercentagevaluewas50.9±13.6%.Atday24,viability

was8.7±2.9%andreached0%after30days.Adelayedprotoscol- icidaleffectwasobservedwith1␮g/mlof5-FU.Inthiscase,the viabilitydiminishedtonear50%after24daysofincubation.Viabil- itywas0%atday48(datanotshown).

TheeffectofPTXwasalsodoseand time-dependent(Fig.3).

At30daysp.i.with10and5␮g/mlPTX,viabilityofprotoscoleces decreasedtoapproximately60%andreached0%after72days(data notshown).Treatmentwith1␮g/mlPTXalsoshowedprotoscolici- daleffect,with75.3%ofparasitesremainingviableincultureafter 30daysofincubation.Asitwasmentioned,5-FUhadastronger effectthandidPTX.Forthisreason,experimentsofinfectivityto miceweredevelopedonlywith5-FU.

Theresultsofviabilitytestcoincidewiththetegumentalalter- ationsobserveddailybyopticalmicroscope(Fig.4).Between2and 4daysp.i.,thepresenceofnumerousblebsinthetegumentofpro- toscolecestreatedwith10,5and1␮g/mlof5-FUwasobserved.

Fig.4.LightmicroscopyofE.granulosusprotoscolecesincubatedinvitrowith5-FUandPTX.(a)Controlprotoscoleces(cc,calcareuscorpuscles;h,hooks;4daysp.i.;300×);

(b)protoscolecesincubatedwith5␮g/ml5-FU(3daysp.i.;400×).Notethelossofhooks(arrow).Vesiculatedprotoscolex(arrowhead);(c)alteredprotoscolexafter3days ofincubationwith10␮g/ml5-FU.Notethepresenceofnumerousblebs(arrow)andthelostofhooks(300×),(d)vesiculatedprotoscolecesafter5dayswith10␮g/mlPTX (300×).

Otheralterationssuchasrostellardisorganizationandcontraction ofposteriorregioncouldbeseenafter3days(Fig.4bandc).After4 daysofincubationwithdifferentconcentrationsofPTX,vesiculated protoscoleceswereobserved(Fig.4d).Tegumentalalterationsin PTX-treatedprotoscolecescouldbeobservedlater,between5and 7daysp.i.

Theseresultswereconfirmedontheultrastructural levelby SEMandTEM(Figs.5and6).Controlculturesexhibitednoultra- structuralalterationsinparasitetissueduringthewholeincubation period(Figs.5aandband6a).Incontrast,morphologicalandultra- structuraldamagesweredetectedin treated protoscoleces.The primarysiteofdamagewasthetegumentoftheparasite.

Theultrastructuraleffectsobservedafter5-FUincubationwere greater than those caused by PTX (Figs. 5c–f and 6b and c).

At 12 days p.i., SEM analysis of protoscoleces incubated with 5-FU showed the presence of tegumental alterations, rostellar

disorganization,lossofhooks,andsheddingofmicrotrichesofthe scolexregion(Fig.5candd).Lossofmorphologywasevidentwith 5-FUatconcentrationof10␮g/ml(Fig.5e).PTXproducedrostellar disorganisationandlossofmicrotrichesoftherostellarregionafter 12days(Fig.5f).

At 12 days p.i.,observations by TEMof 5-FUtreated proto- scolecesrevealedtheinternaltissuealteredwiththepresenceof numerousvacuoles andlipiddroplets (Fig.6b).Upontreatment with PTX for 12 days, the internal tissue of protoscoleces was slightlyvacuolated(Fig.6c).

3.3. Determinationofinfectivitytomice

Controlprotoscolecesdevelopedanaverageof6±2.3gofcysts, similartotheinoculationoffreshly isolatedprotoscoleces. This resultshowedthattheinfectivityofcontrolprotoscoleceswasnot

Fig.5. ScanningelectronmicroscopyofE.granulosusprotoscolecesincubatedinvitrowith5-FUandPTX.(a)Invaginatedcontrolprotoscolex(18daysp.i.;600×);(b) evaginatedcontrolprotoscolex(rr,rostelarregion;s,suckers;sr,somaregion;18daysp.i.;600×);(c)alteredevaginatedprotoscolexincubatedwith1␮g/ml5-FUduring12 days.Thesheddingofmicrotrichescanbeobservedinthescolexregion(700×);(d)Lossofhooksandmicrotrichesandpresenceofnumerousblebs(arrow)(5␮g/ml5-FU;

12daysp.i.;600×);(e)completelossofmorphology.Notethepresenceofnumerousblebs(arrow)(10␮g/ml5-FU;12daysp.i.;850×);(f)alteredprotoscolexafter18days with10␮g/mlPTX(500×).

Fig.6.TEMofE.granulosusprotoscolecesincubatedinvitrowith5-FUandPTX.(a) Somaregionofacontrolprotoscolex(12daysp.i.;g,glycocalix;dc,distalcytoplasm;

12,000×);(b)Treatedprotoscolex(12daysp.i.,10␮g/ml5-FU).Internaltissuewas alteredwiththepresenceofvacuoles(arrows)andlipiddroplets(l)(12,000×);(c) protoscolexincubatedwith10␮g/mlPTX(12daysp.i.).Notethevacuolationofde distalcitoplasmandinternaltissue(arrows)(15,000×).

affectedduringinvitroincubationfor24days.Lossofinfectivity inprotoscolecesincubatedwith5-FUafter24dayswasobserved, sincealloftheprotoscolecesfailedtodevelopintocystsfollowing theirinoculationintomice.

3.4. Invitrocystsincubation

Survivalof cystsincubatedwiththedifferentconcentrations of5-FUandPTXareshowninFig.7.Theeffectwasmorerapidly detectedincyststreatedwith5-FUthanwhenPTXwereused.

AscanbeseeninFig.8,incubationofE.granulosuscystsinthe presenceof5-FUandPTXresultedindramaticalterationswithin 3to5daysafterinitiationoftreatment.Atlowerconcentrations, similarmorphologicalchangesoccurred,althoughatalowerrate (datanotshown).Alreadyvisiblemacroscopically,theparasitetis- suedetachedfromtheinteriorliningofthelaminatedlayerand formedadenselypackedaggregateinsidethevesicles.Thelami- natedlayerbecametranslucent,mostlybecauselargepartsofthe parasitetissuehadbeenredistributedtoanothersite.

InspectionofcontrolcystsbySEMandTEMrevealedthatthey exhibitedtypicalfeaturesofE.granulosusmetacestodes,withadis- tinctacellularouterlaminatedlayerandanintactgerminallayer comprisedofamultitudeofdifferent,morphologicallyintactcell types(Fig.9aandb).

Theultrastructuraleffectobservedafter5-FU-incubationwas greaterthanthatcausedbyPTX.Clearly,after3dayswith5-FU (10␮g/ml)thegerminallayerlostthemulticellularstructurefea- ture(Fig.9c).At10 daysp.i.,studiesbyTEMrevealedcomplete destructionoftheparasitetissue withthepresence oflamellar bodies(Fig.9d).Ontheotherhand,lesscellswereobservedinthe germinallayerofcystsincubatedwith10␮g/mlofPTX(Fig.9e).

After10 days,thepresenceofnumerous vacuoleswasdetected (Fig.9f).

4. Discussion

Many similarities exist between cancer cells and parasites.

Therefore,a promising startingpoint forthediscoveryof novel drugs to combat parasites is to examine available compounds developedagainstcancerforantiparasiticproperties(Klinkert&

Heussler,2006).Severaldrugs inhibiting proliferationof cancer cellshave beenassayedonEchinococcus metacestodesandpro- toscoleces. This work describes for the first time the in vitro anthelminticeffectoftheanti-cancerdrugs5-FUandPTXonE.

granulosuslarvalcells,protoscolecesandcyst.

Thereare numerous routes and schedules of administration available for 5-FU. The weekly bolus administration of 5-FU at 15mg/kg in clinic produces initial peak plasma levels of approximately50to100␮g/mlwhichrapidlydeclinebyseveral ordersofmagnitude(Calabro-Jonesetal.,1982).Arecommended starting doseof single-agent5-FUgiven by protractedinfusion is 300mg/m²/day (Harris et al., 1990). Continuous infusion of 2300mg/m²/dayproduces5-FUserumconcentrationsontheorder of1␮g/ml(Gremetal.,1993).Inaddition,theexposureto1.3␮g/ml 5-FUdoesnotproducecytotoxiceffectonprimaryendometrialcell cultures(epithelialandstromalcells)(Ngôetal.,2010).

AtthemaximumtoleratedandrecommendedPhaseIIdosesfor PTXadministeredasa6-hinfusion,plasmalevelshaveapproached 10␮Mfor2–4h,andhaveexceeded1␮Mfor24h,and0.1␮Mfor 48h(Rowinskyetal.,1988).Besides,PTXdidnotalterthegrowth offibroblastsataconcentrationof8.54␮g/ml(Estesetal.,1998).

Ontheotherhand,cleareffectsonPlasmodiumfalciparumwere demonstratedusing5-FUat1.6␮g/mlconcentration(Rathodetal., 1989).Theactivityagainstapicomplexanparasiteswasdetermined usingPTXatconcentrationsbetween0.25to10␮g/ml(Estesetal.,

Fig.7.SurvivalofE.granulosuscystsaftertreatmentwith5-FUandPTX.Viabilitywasmeasuredonthebasisofvesicleintegrity(DMSO:dimethylsulphoxide).

1998).Itwasthereforedecidedtotest5-FUandPTXatconcentra- tions1,5and10␮g/ml.

Nodifferencesbetweentheeffectof5-FUandPTXontheviabil- ityofgerminalcellswerefound.5-FUorPTXinhibitedthegrowth ofE.granulosuscellsinatimedependentmanner.Moreover,5-FU orPTXataconcentrationof10␮g/mlnotonlyinhibitedthegrowth ofcellsbutalsoprovokedaconsiderablereductioninthecellnum- ber.Cellsexposedto5-FUorPTXshowedmorphologicalalteration aslossofturgidity,cellularcontractionandpresenceofblebson cellsurface.

Interesting,larvalcellsweremoresensitivetothedrugsthan protoscolecesandcysts.Isolatedcellsofgerminallayeraremore exposedtotheactionofthedrugsduetotheyaredetachedfrom theirnormalenvironmentandcouldthusbemoresensitive.Pro- toscolecesandcystsare multicellularorganismssurroundedby tegumentthatactsasbarrieragainstthedrugs(Galindoetal.,2008;

Urrea-Parisetal.,1999).Anotherpossibleexplanationcouldbethat asdrugsprimarilytargetcellsinmitosis,post-mitoticcellsofentire larvaecouldsurvivelonger.

Theefficacyof 5-FUandPTX wasalsodemonstratedinvitro onE.granulosusprotoscoleces,andmarkedly differencesonthe effectivenessofbothdrugsweredetected.5-FUhadaconsiderably strongerprotoscolicidaleffectthandidPTX.Besides,itseffectwas dose-andtime-dependent,provokingthecompletelossofviabil- ityafter24daysofincubation.Incontrast,thelossofviabilitywas slowerinPTXtreatedprotoscoleces,reachingtoapproximately60%

after30days.

Moreover,5-FUwasabletokillE.granulosusprotoscoleces,since followinginoculationoftreatedparasitesinmicenocystscouldbe recoveredafter4monthspostinfectioninallmiceinfectedwith 5-FU-treatedparasites.

Themorphologicalandultrastructuralalterationsincludedcon- tractionofthesomaregion,formationofblebsonthetegument, rostellardisorganization,lossofhooks,sheddingofmicrotriches, andthepresenceofvacuolesandlipiddroplets.Thesamealter- ationshavealsobeenreportedbyotherauthorsworkingwithother

drugslikebenzimidazoles(Pérez-Serranoetal.,1994;Elissondo et al., 2006), praziquantel(Urrea-Paris et al.,2000), ivermectin (Casado et al., 2002; Elissondo et al., 2009), and nitasoxanide (Walkeretal.,2004).

Likewise,5-FUproducedagreatereffectonE:granulosusmurine cystthanthatobservedwithPTX.Acorrelationbetweentheinten- sityofdamageandtheconcentrationofthedrugwasfound.The ultrastructural changesobservedbySEM andTEMincludedthe lossofthecharacteristicmulticellularappearanceofthegermi- nalmembrane.Furthermore,thesameultrastucturalalterationsin cellculturesaftertreatmentwith5-FUandPTXcouldbeobserved.

These changes have been also observed in E. granulosus cysts followinginvitrotreatmentwithothersanticancerdrugssuchas2- methoxyestradiol,genesteinandotherisoflavones(Naguleswaran etal.,2006;Spicheretal.,2008a).Theseultrastructuralchanges weresimilartothosereportedbyothersauthors(Elissondoetal., 2007;Walkeretal.,2004).

Thedifferentmechanismofactioncouldexplainthedisparate efficacyofthesedrugsagainstE.granulosus.5-FUisananalogue of uracil with a fluorine atom at the C-5 position instead of hydrogen.Itrapidlyentersthecellusingthesamefacilitatedtrans- portmechanismasuracil.Thedrugisconvertedintracellularlyto severalactive metabolites:fluoro-deoxyuridinemonophosphate (FdUMP),fluorodeoxyuridinetriphosphate(FdUTP),andfluorouri- dinetriphosphate(FUTP).Theactivemetabolitesof5-FUdisrupt RNAsynthesis(FUTP),inhibittheactionofthymidylatesynthase (TS)–anucleotidesyntheticenzyme(FdUMP)–andcanalsobe directlymisincorporatedintoDNA(FdUTP)(Longleyetal.,2003).

E.granulosusgenomeencodesaTS(EgrG000260100)(Zhengetal., 2013)withconsiderablehomologywithdehumanenzyme.

Bytheotherhand,PTXpromotestheassemblyofmicrotubules andstabilizestubulinpolymersbypreventingtheirdepolymeriza- tion.Thisunusualstabilityresultsintheinhibitionofthenormal dynamicreorganizationofthemicrotubulenetwork(Blagosklonny and Fojo, 1999). Since microtubules are important for mitosis andinterphasefunctionssuchasmaintenanceofcellshape,cell

Fig.8.Morphologicaleffectsof5-FUandPTXtreatmentsonE.granulosuscysts.(a)Controlcyst(3daysp.i.);(b)cystincubatedwith10␮g/mlof5-FU(arrow,germinallayer;

3daysp.i.);(c)cystincubatedwith10␮g/mlofPTX(arrow,germinallayer;5daysp.i.).Bar=300␮m.

Fig.9.RepresentativeimagesofSEMandTEMofmurinecystsincubatedinvitrowith5-FUandPTX.((a)and(b))Controlcysts(a)controlcystwithanintactgerminallayer (gl,germinallayer;ll,laminarlayer;3daysp.i.;SEM500×);(b)Controlcyst(ll,laminarlayer;mt,microtriches;dc,distalcitoplasm;10daysp.i.;TEM12,000×);((c)and(d)) cystincubatedwith10␮g/ml5-FU.(c)Notetheextensivedamageofthegerminallayer(3daysp.i.;SEM300×)(d)Theinternaltissuewasseverelyaffected((b)residual lamillarbodies;10daysp.i.;TEM15,000×);((d)and(e))cystsincubatedwith10␮g/mlPTX.(d)Thegerminallayerisaltered(3daysp.i.;SEM250×);(e)notethepresence ofvacuoles(arrows)(10daysp.i.;TEM12,000×).

motility,and intracellular transport, PTX might beexpected to affectcells duringbothinterphaseandmitoticcellcyclephases (Rowinskyetal.,1988).

In thesearch foran effectivedrug againstE. granulosus, we showedthat5-FUandPTX,atclinicallyachievableconcentrations, inhibitedthesurvivaloflarvalcells,protoscolecesandmetaces- todes.Invivostudiestotesttheantiparasiticactivitiesof5-FUand PTXarecurrentlybeingundertakenonthemurinemodelofcystic echinococcosis.

Acknowledgements

Thisworkwassupportedby thePICT12 no.1164(ANPCyT, Argentina), PIP 0029 (CONICET, Argentina) and Universidad Nacional de Mar del Plata (Grant EXA 581/12 and Grant EXA 672/14),Argentina.

References

Albani, C.M., Elissondo, M.C., Cumino, A.C., Chisari, A., Denegri, G.M., 2010.

PrimarycellcultureofEchinococcusgranulosusdevelopedfromthecysticger- minallayer: biologicalandfunctionalcharacterization.Int.J.Parasitol.40, 1269–1275.

Ayres,M.,AyresJr.,M.,Ayres,D.L.,Santos,A.S.,2007.BioEstat5.0aplicac¸õesestatís- ticasnasáreasdasciênciasbiomédicas,fifthed.ImprensaOficialdoEstadodo Pará,Brazil.

Blagosklonny,M.V.,Fojo,T.,1999.Moleculareffectsofpaclitaxel:mythsandreality (acriticalreview).Int.J.Cancer83,151–156.

Brunetti,E.,Garcia,H.H.,Junghanss,T.,2011.Cysticechinococcosis:chronic,com- plex,andstillneglected.PLoSNegl.Trop.Dis.5(7),e1146.

Budke,C.M.,Carabin,H.,Ndimubanzi,P.C.,Nguyen,H.,Rainwater,E.,Dickey,M., Bhattarai,R.,Zeziulin,O.,Qian,M.B.,2013.ASystematicreviewofthelitera- tureoncysticechinococcosisfrequencyworldwideanditsassociatedclinical manifestations.Am.J.Trop.Med.Hyg.88,1011–1027.

Bygott,J.M.,Chiodini,P.L.,2009.Praziquantel:Neglecteddrug?Ineffectivetreat- ment? Or therapeutic choice in cystic hydatid disease? Acta Trop. 111, 95–101.

Calabro-Jones,P.M.,Byfield,J.E.,Ward,J.F.,Sharp,T.R.,1982.Time–doserelation- shipsfor5-fluorouracilcytotoxicityagainsthumanepithelialcancercellsin vitro.CancerRes.42,4413–4420.

Casado,N.,Moreno,M.,Urrea-París,M.,Rodríguez-Caabeiro,F.,2002.Couldiver- mectinhaveasynergiceffectwithalbendazoleinhydatidosistherapy?Invitro studies.Parasitol.Res.88,153–159.

Ceballos,L.,Elissondo,M.C.,Moreno,L.,Dopchiz,M.,SánchezBruni,S.,Denegri,G., Alvarez,L.,Lanusse,C.,2008.Albendazoletreatmentincysticechinococcosis:

pharmacokineticsandclinicalefficacyoftwodifferentaqueousformulations.

Parasitol.Res.103,355–362.

Elissondo,M.C.,Ceballos,L.,Alvarez,L.,SánchezBruni,S.,Lanusse,C.,Denegri,G., 2009.Flubendazoleandivermectininvitrocombinationtherapyproducesa markedeffectonEchinococcusgranulosusprotoscolecesandmetacestodes.Para- sitol.Res.105,835–842.

Elissondo,M.C.,Ceballos,L.,Dopchiz,M.,Andresiuk,V.,Alvarez,L.,SánchezBruni, S.,Lanusse,C.,Denegri,G.,2007.Invitroandinvivoeffectsofflubendazoleon Echinococcusgranulosusmetacestodes.Parasitol.Res.100,1003–1009.

Elissondo,M.C.,Dopchiz,M.,Ceballos,L.,Alvarez,L.,SánchezBruni,S.,Lanusse,C., Denegri,G.,2006.InvitroeffectsofflubendazoleonEchinococcusgranulosus protoscoleces.Parasitol.Res.98,317–323.

Estes,R.,Vogel,N.,Mack,D.,McLeod,R.,1998.Paclitaxelarrestsgrowthofintracel- lularToxoplasmagondii.Antimicrob.AgentsChemother.42,2036–2040.

Galindo,M.,Schadebrodt,G.,Galanti,N.,2008.Echinococcusgranulosus:cellularter- ritoriesandmorphologicalregionsinmatureprotoscoleces.Exp.Parasitol.199, 524–533.

Grem,J.L.,McAtee,N.,Steinberg,S.M.,Hamilton,J.M.,Murphy,R.F.,Drake,J.,Chisena, T.,Balis,F.,Cysyk,R.,Aibuck,S.G.,Sorensen,J.M.,Chen,A.P.,Goldstein,L.,Jordan, E.,Setser,A.,Goldspiel,B.,DeCarvalho,M.,Allegra,C.J.,1993.APhaseIstudyof continuousinfusion5-fluorouracilpluscalciumleucovorinincombinationwith N-(phosphonacetyl)-l-aspartateinmetastaticgastrointestinaladenocarcinoma.

CancerRes.53,4828–4836.

Harris,B.E.,Song,R.,Soong,S.J.,Diasio,R.B.,1990.Relationshipbetweendihydropy- rimidinedehydrogenaseactivityandplasma5-fluorouracillevelswithevidence forcircadianvariationofenzymeactivityandplasmadruglevelsincancer patientsreceiving5-fluorouracilbyprotractedcontinuousinfusion.CancerRes.

50,197–201.

Heidelberger,C.,Chaudhuari,N.K.,Daneberg,P.,Mooreh,D.,Griesbach,L.,Duschin- sky,K.,Schnitzer,R.J.,Pleven,E:,1957.Fluorinatedpyrimidines.Anewclassof tumorinhibitorycompounds.Nature179,663–666.

Hemer,S.,Brehm,K.,2012.Invitroefficacyoftheanticancerdrugimatinibon Echinococcusmultilocularislarvae.Int.J.Antimicrob.Agents40,458–462.

Hemphill,A.,Müller,J.,2009.Alveolarandcysticechinococcosis:towardsnovel chemotherapeuticaltreatmentoptions.J.Helminthol.83,99–111.

Hemphill,A.,Spicher,M.,Stadelmann,B.,Mueller,J.,Naguleswaran,A.,Gottstein,B., Walker,M.,2007.Innovativechemotherapeuticaltreatmentoptionsforalveolar andcysticechinococcosis.Parasitology134,1657–1670.

Huizing,M.T.,SewberathMisser,V.H.,Pieters,R.C.,tenBokkelHuinink,W.W.,Veen- hof,C.H.N.,Vermorken,J.B.,Pinedo,H.M.,Beijnen,J.H.,1995.Taxanes:anew classofantitumoragents.CancerInvest.13,381–404.

Hübner,C.,Wiehr,S.,Kocherscheidt,L.,Wehrl,H.,Pichler,B.J.,Schmid,A.,Kern, P.,Soboslay,P.T.,2010.EffectsofinvitroexposureofEchinococcusmultilocu- larismetacestodestocytostaticdrugsoninvivogrowthandproliferationofthe parasite.Parasitol.Res.107,459–463.

Klinkert,M.Q.,Heussler, V.,2006.Theuseofanticancerdrugsinantiparasitic chemotherapy.MiniRev.Med.Chem.6,131–143.

Küster,T.,Lense,N.,Barna,F.,Hemphill,A.,Kindermann, M.K.,Heinicke, J.W., Vock,C.A.,2012. Anewpromising applicationfor highlycytotoxic metal compounds:␩6-areneruthenium(II)phosphitecomplexesforthetreatmentof alveolarechinococcosis.J.Med.Chem.55,4178–4188.

Liance,M.,Nemati,F.,Bories,C.,Couvreur,P.,1993.Experiencewithdoxorubicin- boundpolyisohexylcyanoacrylatenanoparticlesonmurinealveolarechinococ- cosisoftheliver.Int.J.Parasitol.23,427–429.

Longley,D.B.,Harkin,D.P.,Johnston,P.G.,2003.5-Fluorouracil:mechanismsofaction andclinicalstrategies.Nat.Rev.Cancer3,330–338.

McManus,D.P.,Gray,D.J.,Zhang,W.,Yang,Y.,2012.Diagnosis,treatment,andman- agementofechinococcosis.Br.J.Med.Med.Res.344,39–44.

Moro, P., Schantz,P.M., 2009. Echinococcosis: areview. Int. J. Infec.Dis. 13, 125–133.

Naguleswaran,A.,Spicher,M.,Vonlaufen,N.,Ortega-Mora,L.M., Torgerson,P., Gottstein,B.,Hemphill,A.,2006.Invitrometacestodicidalactivitiesofgenis- teinandotherisoflavonesagainstEchinococcusmultilocularisandEchinococcus granulosus.Antimicrob.AgentsChemother.50,3770–3778.

Ngô,C.,Nicco,C.,Leconte,M.,Chéreau,C.,Weill,B.,Batteux,F.,Chapron,C.,2010.

Antiproliferativeeffectsofanastrozole,methotrexate,and5-fluorouracilon endometriosisinvitroandinvivo.Fertil.Steril.94,1632–1638.

Pawlowski,Z.S.,Eckert,J.,Vuitton,D.A.,Ammann,R.W.,Kern,P.,Craig,P.S.,Dar, K.F.,DeRosa,F.,Filice,C.,Gottstein,B.,Grimm,F.,Macpherson,C.N.L.,Sato,N., Todorov,T.,Uchino,J.,vonSinner,W.,Wen,H.,2001.Echinococcosisinhumans:

clinicalaspects,diagnosisandtreatment.In:Eckert,J.,Gemmell,M.A.,Meslin, F.X.,Pawlowski,Z.S.(Eds.),WHO/OIEManualonEchinococcosisinHumansand Animals:APublicHealthProblemofGlobalConcern.WorldOrganisationfor AnimalHealth,Paris,France,pp.20–66.

Pérez-Serrano,J.,Casado,N.,Denegri,G.,Rodríguez-Caabeiro,F.,1994.Theeffectsof albendazoleandalbendazolesulphoxidecombination-therapyonEchinococcus granulosusinvitro.Int.J.Parasitol.24,219–224.

Pouvelle,B.,Farley,P.J.,Long,C.A.,Taraschi,T.F.,1994.Taxolarreststhedevelopment ofblood-stagePlasmodiumfalciparuminvitroandPlasmodiumchabaudiadami inmalaria-infectedmice.J.Clin.Invest.94,413–417.

Rathod,P.K.,Khatri,A.,Hubbert,T.,Milhous,W.K.,1989.Selectiveactivityof5- fluorooroticacidagainstPlasmodiumfalciparuminvitro.Antimicrob.Agents Chemother.33,1090–1094.

Rowinsky,E.K.,Donerhower,R.C.,1995.Paclitaxel(taxol).N.Engl.J.Med.332, 1004–1014.

Rowinsky,E.K.,Donehower,R.C.,Jones,R.J.,Tucker,R.W.,1988.Microtubulechanges andcytotoxicity inleukemiccelllinestreatedwithtaxol. CancerRes. 48, 4093–4100.

Rutman,R.J.,Cantarow,A.,Paschkis,K.E.,1954.Studieson2-acetylaminofluorene carcinogenesis:III.Theutilizationofuracil-2-C14bypre-neoplasticratliver.

CancerRes.14,119–123.

Spicher,M.,Naguleswaran,A.,Ortega-Mora,L.M.,Müller,J.,Gottstein,B.,Hemphill, A.,2008a.Invitroandinvivoeffectsof2-methoxyestradiol,eitheraloneor combinedwithalbendazole,againstEchinococcusmetacestodes.Exp.Parasitol.

119,475–482.

Spicher,M.,Roethlisberger,C.,Lany,C.,Stadelmann,B.,Keiser,J.,Ortega-Mora,L.M., Gottstein,B.,Hemphill,A.,2008b.InvitroandinvivotreatmentsofEchinococcus protoscolecesandmetacestodeswithartemisininandartemisininderivatives.

Antimicrob.AgentsChemother.52,3447–3450.

Stamatakos,M.,Sargedi,C.,Stefanaki,C.,Safioleas,C.,Matthaiopoulou,I.,Safioleas, M.,2009.Anthelminthictreatment:anadjuvanttherapeuticstrategyagainst Echinococcusgranulosus.Parasitol.Int.58,115–120.

Stojkovic,M.,Zwahlen,M.,Teggi,A.,Vutova,K.,Cretu,C.M.,Virdone,R.,Nicolaidou, P.,Cobanoglu,N.,Junghanss,T.,2009.Treatmentresponseofcysticechinococ- cosistobenzimidazoles:asystematicreview.PLoSNegl.Trop.Dis.3,e524, http://dx.doi.org/10.1371/journal.pntd.0000524.

Urrea-Paris,M.,Moreno,M.,Casado,N.,Rodriguez-Caabeiro,F.,1999.Echinococcus granulosus:praziquanteltreatmentagainstthemetacestodestage.Parasitol.Res.

85,999–1006.

Urrea-Paris,M.,Moreno,M.,Casado,N.,Rodríguez-Caabeiro,F.,2000.Invitroeffect ofpraziquanteandalbendazolecombinationtherapyofthelarvalstageof Echinococcusgranulosus.Parasitol.Res.86,957–964.

Walker,M.,Rossignol,J.,Torgerson,P.,Hemphill,A.,2004.Invitroeffectsofnitazox- anideonEchinococcusgranulosusprotoscolecesandmetacestodes.J.Antimicrob.

Chemother.54,609–616.

Wani,M.,Taylor,H.L.,Wall,M.E.,1971.PlantantitumoragentsVI.Theisolation andstructureofTaxol,anovelantileukemicandantitumoragentfromTaxus brevifolia.J.Am.Chem.Soc.93,2325–2327.

Zheng,H.,Zhang,W.,Zhang,L.,Zhang,Z.,Li,J.,Lu,G.,Zhu,Y.,Wang,Y.,Huang,Y.,Liu, J.,Kang,H.,Chen,J.,Wang,L.,Chen,A.,Yu,S.,Gao,Z.,Jin,L.,Gu,W.,Wang,Z.,Zhao, Li.,Shi,B.,Wen,H.,Lin,R.,Jones,K.,Brejova,M.,Vinar,B.,Zhao,T.,McManus,G., Zhou,Z.D.,Wang,Y.S.,2013.ThegenomeofthehydatidtapewormEchinococcus granulosus.Nat.Genet.45,1168–1175.